Convey's Family of Companies
Follow HealthScape:
HEALTHCARE SOLUTIONS
DATA & ANALYTICS
ADVISORY PARTNER
WANT TO LEARN MORE?
Our Insights

Executive Briefing | July 26, 2023

2024 AEP: The Most Competitive Marketing Season Ever

By , , ,

As Medicare Advantage Organizations (MAOs) get ready for the upcoming Annual Enrollment Period (AEP), they should proactively prepare for one of the most competitive marketing seasons to date. The cumulative impact from changes in payment rates; regulatory pressure on Third…

Read More

Executive Briefing | March 14, 2023

HealthScape Advisors’ Insights on 2023 AEP Performance

By , ,

This brief builds upon last year’s analysis of Medicare’s Annual Enrollment Period (AEP) and highlights results from the most recent enrollment data available1 from the Centers for Medicare and Medicaid Services (CMS) that accounts for 2023 AEP. Where helpful, we’ll compare…

Read More

Executive Briefing | February 14, 2023

Supplemental Benefit Trends 2023

By , ,

Studies have previously suggested that MA members are “sticky” and rarely change coverage; however, this behavior may be changing given the proliferation of product options and availability of rich benefits. For example, at the recent JP Morgan Healthcare Conference, Humana…

Read More

Article | April 26, 2022

HealthScape Advisors’ Preliminary Insights on 2022 AEP – March Update

By , , ,

In late February 2022, HealthScape published an initial review of Annual Enrollment Period (AEP) results, noting material changes to Medicare Advantage (MA) membership from December 2021 to January 2022 (when AEP enrollments went into effect) across nearly 300 carriers, including…

Read More

Executive Briefing | February 22, 2022

HealthScape Advisors’ Preliminary Insights on 2022 AEP

By , ,

This brief details HealthScape Advisors’ first look at Medicare Advantage (MA) 2022 Annual Enrollment Period (AEP) results. As additional enrollment data becomes available from the Centers for Medicare and Medicaid Services (CMS), we will update this brief with any significant…

Read More